Profile
Matthew P.
Ottmer worked as Senior VP-Strategy & Emerging Businesses at Biogen, Inc. from 2014 to 2015, followed by a position as Chief Operating Officer at Momenta Pharmaceuticals, Inc. from 2015 to 2017.
He then became President at Bioverativ Therapeutics, Inc. before serving as Chief Operating Officer at Voyager Therapeutics, Inc. from 2017 to 2020.
Ottmer received his undergraduate degree from the University of Michigan and his MBA from Kellogg School of Management.
Former positions of Matthew P. Ottmer
| Companies | Position | End |
|---|---|---|
| VOYAGER THERAPEUTICS, INC. | Chief Operating Officer | 2020-02-11 |
| MOMENTA PHARMACEUTICALS, INC. | Chief Operating Officer | 2017-03-31 |
| BIOGEN INC. | Corporate Officer/Principal | 2015-06-30 |
Bioverativ Therapeutics, Inc.
Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | President | - |
Training of Matthew P. Ottmer
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Momenta Pharmaceuticals, Inc.
Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that discovers and develops novel biologic therapies for the treatment of rare immune-mediated diseases | Health Technology |
Bioverativ Therapeutics, Inc.
Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kellogg School of Management
Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Voyager Therapeutics, Inc.
Voyager Therapeutics, Inc. BiotechnologyHealth Technology Develops gene therapies for fatal and debilitating diseases of the central nervous system | Health Technology |
- Stock Market
- Insiders
- Matthew P. Ottmer
















